Follow Us:

Turn a Few Minutes of Time
Into a Steady Income…

This week Int’l Live Trading Champion, Chuck Hughes is giving away his latest eBook revealing a strategy so powerful that over the past 5 years it has produced profits totaling $4.4 Million...

Yet it’s so simple it takes just 10 minutes a month to do!

10-Minute Secret
To Spectacular Profits

This one moneymaking secret could change your entire financial future. And I promise, you won’t find it anywhere else!

Learn how ordinary men and women with no prior trading experience... Are turning just a few minutes of time into a steady income of $5,000 - $20,000 month!

As an exciting extra bonus you’ll also gain access to an eye-opening video that reveals something important to your financial future recently learned from the FBI...

So go ahead, grab your copy while you can, and see what happens when you do!

10-Minute Secret
To Spectacular Profits

Dave Caplan founded and is former President of Opportunities in Options in Malibu, California, a firm that specializes in analyzing and identifying potential option trades with the best returns and the lowest risks. A pioneer in innovative option trading strategies, he is the author of several best-selling books including The Options Advantage, The Options Secret and Trade Options Like a Bookie.

This book is an indispensable tool for all option traders. Inside, renowned publisher, speaker and author Dave Caplan explains how to use volatility as a measure of under- and over-valuation on any option. This, according to Caplan, can put the odds of success (profitability) in your favor up to 90% of the time. Coupled with the limited risk inherent in options, that measurement of volatility is the true key to realizing consistent profits in options. Caplan explains it all, in clear and concise language, in the pages of this breakthrough book. And you can get a copy now at half the regular price. Supplies are limited, so order soon!

Learn More About the
#1 Option Trading Weapon

The Option Secret

Better Business Bureau

by Dave Caplan

The following is an excerpt from Dave Caplan's The Option Secret

The two concepts of “strategies” and “uses” blend or cross over where options are concerned because options are so versatile. They come in all sizes, shapes and colors. Some are built for speed; others for dependability and smooth sailing. Still others are very crafty, putting the odds in your favor. Which suits you?

There are basically two types of options traders, namely, speculators and hedgers. The speculators are risk takers, while the hedgers wish to transfer risk to someone else. The objective of the speculators is to generate profits. Hedgers want to preserve the status quo. We’ll probe the role of the speculators first, since this is what most traders are. Then we’ll tackle the hedging because it can have a dramatic impact on the speculators. Some investors who speculate in one market, such as stocks, can manage or hedge that risk in another one, such as the options market.

All speculators are not created equal, but all have the same goal (profits) even though their strategies vary widely. Also, the complexion of the market can strongly influence or change your approach. You must be more flexible than the markets you trade to win.

As you develop your strategies, keep two things in mind – the Power of Leverage and the Law of Probability. Leveraging allows you to control a large amount of a commodity, or a large number of shares of a stock, with a small amount of capital. For example, let’s say corn is trading at $2.10 per bushel and the $2.10 strike price call is trading for $0.055 (5 ½ cents). The contract has six weeks to expiration. You would have control of $10,500 worth of corn with an option that costs $275, plus commission and fees for a total of $325. Your leveraging ratio would be 32 to 1 ($10,500/$325). A similar situation in the stock market would be the purchase of an AT&T $40 per share call at 1 7/8 ($1.875), or $187.50 (100 shares x $1.875), plus $40 transaction costs. If the stock is at 41 ¼ or $41.25 per share at the time, the total value of 100 shares would be $4,125. Divide this by the total invested giving you a ratio of approximately 18:1 ($4,125/227.50).

Now, what does leveraging do for you? It gives you the opportunity to make a high return percentage wise on your investment. Take the corn example. When corn gains a dime, the total value of the contract increases $500. Your $2.10 option is at-the-money. Therefore, its intrinsic value would increase by an equal amount or a 65% return. Additionally, there could be some increase in the time value, depending on how much left to expira

You would have a similar situation with the stock option. It’s for 100 shares, therefore, every $1.00 gain per share increases the value of the in-the-money option by at least $100 of intrinsic value. A gain of $4 per share doubles your investment.

Your Personal Trading Strategy

by Lee Gettess

Lee Gettess is a top trader who is excited to bring you his video newsletter. Each week, Lee will share his predictions on what he anticipates from the bond and S&P markets.

Watch Video

by Andy Chambers

Andy Chambers shares a clip from his 'Upside Trading Strategies' DVD about reading swing highs and swing lows in the marketplace. He talks about how to identify swings that make up the trend. Using examples of actual trades, Andy provides profitable trade set-ups.

Watch Video

by Chuck Hughes

The following is an excerpt from Chuck Hughes' Optioneering Newsletter

Every week Chuck publishes his “Optioneering Newsletter”. The following are trade updates from his most recent issue.

Mini Dow Futures Monthly: Bullish trading in November could mark the beginning of the next leg of the long-term bull trend. If so, the uptrend could go much further and last a long time. Of course, there will be corrections along the way.

The first profit opportunity we will review this week is in GWPH, or GW Pharmaceuticals. GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product Sativex. Sativex is the first natural cannabis plant derivative product to gain market approval in any country. Another cannabis based product, Epidiolex, for treatment of epilepsy, underwent phase 3 clinical trials in 2015.

GWPH Monthly: The monthly chart shows that GWPH hit a new record high in October. New record highs are bullish.

To Learn More Click Here